Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Frequently asked questions
What sector does Pulse Biosciences Inc (PLSE) operate in?
Pulse Biosciences Inc belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Pulse Biosciences Inc (PLSE) current stock price?
As of the latest data, Pulse Biosciences Inc stock price is $52.66, with a previous close of $53.02. Pulse Biosciences Inc lost -$0.36 in the last trading session, representing a -0.68% loss.
What is Pulse Biosciences Inc (PLSE) current market capitalization?
Pulse Biosciences Inc market cap is approximately 3.76 billion.
What is Pulse Biosciences Inc (PLSE) Earnings Per Share (EPS)?
The trailing EPS is -$1.18, and the forward EPS is -$1.17.
What is Pulse Biosciences Inc (PLSE) EBITDA?
Pulse Biosciences Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -24.40 million.
Does Pulse Biosciences Inc (PLSE) pay dividends?
No. Pulse Biosciences Inc does not pay a dividend.
How did Pulse Biosciences Inc (PLSE) perform in its most recent earnings report?
In the last report (June 30, 2026), Pulse Biosciences Inc posted an EPS surprise of -16.13% and a revenue surprise of -18.62%.
When is Pulse Biosciences Inc (PLSE) next earnings report?
Pulse Biosciences Inc is expected to release its next earnings report on September 30, 2026.
What is Pulse Biosciences Inc (PLSE) beta (volatility) score?
Pulse Biosciences Inc has a beta of 1.570, suggesting it is more volatile than the market.
